Search research articles
Contact Us
Filters
Showing results (491-500 of 506) with videos related to
Page
of 51
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 5, 2021
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, et al.
The Journal of Allergy and Clinical Immunology. Global
|
January 25, 2024
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection
Cody J Lauritsen, Ivy V Trinh, Srushti P Desai, et al.
Science Translational Medicine
|
July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects
Michelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Bone
|
December 3, 2014
Lack of prolidase causes a bone phenotype both in human and in mouse
Roberta Besio, Silvia Maruelli, Roberta Gioia, et al.
The Journal of Allergy and Clinical Immunology. Global
|
April 9, 2024
Altered COVID-19 immunity in children with asthma by atopic status
Sherry Tong, Jordan C Scott, Enwono Eyoh, et al.
Immunity
|
April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Bronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Cell Host & Microbe
|
August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Scientific Reports
|
April 17, 2026
Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients
Sean M Litwin, Ivy V Trinh, Shuangyi Bai, et al.
Biorxiv : the Preprint Server for Biology
|
November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)
|
January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Page
of 51
Search research articles
Search
Showing results (491-500 of 506) with videos related to
Sort By:
Page
of 51
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 5, 2021
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, et al.
The Journal of Allergy and Clinical Immunology. Global
|
January 25, 2024
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection
Cody J Lauritsen, Ivy V Trinh, Srushti P Desai, et al.
Science Translational Medicine
|
July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects
Michelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Bone
|
December 3, 2014
Lack of prolidase causes a bone phenotype both in human and in mouse
Roberta Besio, Silvia Maruelli, Roberta Gioia, et al.
The Journal of Allergy and Clinical Immunology. Global
|
April 9, 2024
Altered COVID-19 immunity in children with asthma by atopic status
Sherry Tong, Jordan C Scott, Enwono Eyoh, et al.
Immunity
|
April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Bronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Cell Host & Microbe
|
August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Scientific Reports
|
April 17, 2026
Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients
Sean M Litwin, Ivy V Trinh, Shuangyi Bai, et al.
Biorxiv : the Preprint Server for Biology
|
November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)
|
January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Page
of 51